Patents by Inventor Alexander ASSMANN

Alexander ASSMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11542200
    Abstract: A composition may be suitable for flowable refractory materials and include calcium aluminate cement, a filler, a plasticizer in the form of a copolymer comprising polyether side chains, and a retarder having at least one acid. An article may include such a composition.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: January 3, 2023
    Inventors: Adolf Faerberboeck, Konrad Wutz, Alexander Assmann, Torben Gaedt
  • Patent number: 11387641
    Abstract: A fitting for receiving an insulated lead and a method for assembly thereof are provided. The fitting comprises an elongate member, a sleeve, a collar, and an insulator. The elongate member comprises a first end, a second end, and an interior surface defining an elongate cavity. The first end is open. The sleeve is configured to receive the insulated lead. The first end is configured to receive the sleeve. The collar is configured to compress the sleeve onto the insulated lead to form a seal between the insulated lead and the elongate member. The insulator is configured to inhibit electrical contact between an inner conductor of the insulated lead and the interior surface of the elongate member.
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: July 12, 2022
    Assignee: CHROMALOX, INC.
    Inventors: Danny Rech, Walter Baus, Alexander Assmann
  • Publication number: 20210391700
    Abstract: A fitting for receiving an insulated lead and a method for assembly thereof are provided. The fitting comprises an elongate member, a sleeve, a collar, and an insulator. The elongate member comprises a first end, a second end, and an interior surface defining an elongate cavity. The first end is open. The sleeve is configured to receive the insulated lead. The first end is configured to receive the sleeve. The collar is configured to compress the sleeve onto the insulated lead to form a seal between the insulated lead and the elongate member. The insulator is configured to inhibit electrical contact between an inner conductor of the insulated lead and the interior surface of the elongate member.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 16, 2021
    Inventors: Danny Rech, Walter Baus, Alexander Assmann
  • Publication number: 20210261463
    Abstract: A composition may be suitable for flowable refractory materials and include calcium aluminate cement, a filler, a plasticizer in the form of a copolymer comprising polyether side chains, and a retarder having at least one acid. An article may include such a composition.
    Type: Application
    Filed: June 25, 2019
    Publication date: August 26, 2021
    Applicant: BASF SE
    Inventors: Adolf FAERBERBOECK, Konrad WUTZ, Alexander ASSMANN, Torben GAEDT
  • Publication number: 20210100928
    Abstract: The present invention provides an improved tissue adhesive to repair defects in soft tissue. Following ASTM standard tests, crosslinked methacryloyl-substituted gelatin hydrogels of the present invention (GelSEAL) were shown to exhibit adhesive properties, i.e. wound closure strength, shear resistance and burst pressure, that were superior to clinically used fibrin- and poly(ethylene glycol)-based glues. Chronic in vivo experiments in rats proved GelSEAL to effectively seal large lung leakages without additional sutures or staples, presenting improved performance as compared to fibrin and poly(ethylene glycol) glues. Furthermore, subcutaneous implantation in rats revealed high biocompatibility of GelSEAL as evidenced by low inflammatory host response.
    Type: Application
    Filed: October 6, 2020
    Publication date: April 8, 2021
    Inventors: Ali Khademhosseini, Nasim Annabi, Alexander Assmann
  • Patent number: 10814032
    Abstract: The present invention provides an improved tissue adhesive to repair defects in soft tissue. Following ASTM standard tests, crosslinked methacryloyl-substituted gelatin hydrogels of the present invention (GelSEAL) were shown to exhibit adhesive properties, i.e. wound closure strength, shear resistance and burst pressure, that were superior to clinically used fibrin- and poly(ethylene glycol)-based glues. Chronic in vivo experiments in rats proved GelSEAL to effectively seal large lung leakages without additional sutures or staples, presenting improved performance as compared to fibrin and poly(ethylene glycol) glues. Furthermore, subcutaneous implantation in rats revealed high biocompatibility of GelSEAL as evidenced by low inflammatory host response.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: October 27, 2020
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Ali Khademhosseini, Nasim Annabi, Alexander Assmann
  • Patent number: 10144671
    Abstract: A process for hydrophobization of concrete or mortar using an aqueous dispersion containing an alkylketene dimer, at least one emulsifier and a condensation product of phenol sulfonic acid and formaldehyde, naphthalene sulfonic acid and formaldehyde, or naphthalene sulfonic acid, phenol, formaldehyde and urea; and the concrete or mortar obtainable by the process. The process allows effective mass and surface hydrophobization of concrete.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: December 4, 2018
    Assignee: BASF SE
    Inventors: Uwe Gehrig, Alexander Assmann, Klaus Seip, Martin Pichler, Torben Gädt
  • Patent number: 9926233
    Abstract: The present invention relates to a construction chemical composition comprising Portland cement, a water retention agent, a dispersing agent, and a hardening accelerator comprising calcium-silicate-hydrate, as well as a mortar composition containing said construction chemical composition. Although the composition is based on Portland cement it has a pull-off strength after 6 h meeting the DIN requirements and can therefore be used as a fast setting tile mortar.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: March 27, 2018
    Assignee: BASF SE
    Inventors: Alexander Assmann, Christian Biro, Christoph Hesse
  • Publication number: 20170275204
    Abstract: The present invention relates to a construction chemical composition comprising Portland cement, a water retention agent, a dispersing agent, and a hardening accelerator comprising calcium-silicate-hydrate, as well as a mortar composition containing said construction chemical composition. Although the composition is based on Portland cement it has a pull-off strength after 6 h meeting the DIN requirements and can therefore be used as a fast setting tile mortar.
    Type: Application
    Filed: December 17, 2015
    Publication date: September 28, 2017
    Inventors: Alexander ASSMANN, Christian BIRO, Christoph HESSE
  • Publication number: 20170240468
    Abstract: The invention relates to a process for hydrophobization of concrete or mortar using an alkylketene dimer dispersion and to the concrete or mortar obtainable by the process of the invention. The process allows to achieve effective mass and surface hydrophobization of concrete.
    Type: Application
    Filed: October 23, 2015
    Publication date: August 24, 2017
    Inventors: Uwe GEHRIG, Alexander ASSMANN, Klaus SEIP, Martin PICHLER, Torben GÄDT
  • Publication number: 20170232138
    Abstract: The present invention provides an improved tissue adhesive to repair defects in soft tissue. Following ASTM standard tests, crosslinked methacryloyl-substituted gelatin hydrogels of the present invention (GelSEAL) were shown to exhibit adhesive properties, i.e. wound closure strength, shear resistance and burst pressure, that were superior to clinically used fibrin- and poly(ethylene glycol)-based glues. Chronic in vivo experiments in rats proved GelSEAL to effectively seal large lung leakages without additional sutures or staples, presenting improved performance as compared to fibrin and poly(ethylene glycol) glues. Furthermore, subcutaneous implantation in rats revealed high biocompatibility of GelSEAL as evidenced by low inflammatory host response.
    Type: Application
    Filed: August 6, 2015
    Publication date: August 17, 2017
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Ali KHADEMHOSSEINI, Nasim ANNABI, Alexander ASSMANN